Table of Contents Author Guidelines Submit a Manuscript
Journal of Drug Delivery
Volume 2016, Article ID 8520629, 8 pages
http://dx.doi.org/10.1155/2016/8520629
Research Article

Targeted Delivery of Glucan Particle Encapsulated Gallium Nanoparticles Inhibits HIV Growth in Human Macrophages

Program in Molecular Medicine, University of Massachusetts Medical School, 373 Plantation Street, Worcester, MA 01605, USA

Received 23 August 2016; Accepted 17 October 2016

Academic Editor: Jia You Fang

Copyright © 2016 Ernesto R. Soto et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Soto and G. Ostroff, “Characterization of multilayered nanoparticles inside yeast cell wall particles for DNA delivery,” Bioconjugate Chemistry, vol. 19, no. 4, pp. 840–848, 2008. View at Publisher · View at Google Scholar
  2. M. Aouadi, G. J. Tesz, S. M. Nicoloro et al., “Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation,” Nature, vol. 458, no. 7242, pp. 1180–1184, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Huang, G. R. Ostroff, C. K. Lee, J. P. Wang, C. A. Specht, and S. M. Levitz, “Distinct patterns of dendritic cell cytokine release stimulated by fungal β-glucans and toll-like receptor agonists,” Infection and Immunity, vol. 77, no. 5, pp. 1774–1781, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. G. J. Tesz, M. Aouadi, M. Prot et al., “Glucan particles for selective delivery of siRNA to phagocytic cells in mice,” Biochemical Journal, vol. 436, no. 2, pp. 351–362, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. C. A. Specht, C. K. Lee, H. Huang et al., “Protection against experimental cryptococcosis following vaccination with glucan particles containing Cryptococcus alkaline extracts,” mBio, vol. 6, no. 6, pp. 1–11, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. E. R. Soto, A. C. Caras, L. C. Kut, M. K. Castle, and G. R. Ostroff, “Glucan particles for macrophage targeted delivery of nanoparticles,” Journal of Drug Delivery, vol. 2012, Article ID 143524, 13 pages, 2012. View at Publisher · View at Google Scholar
  7. E. Soto, Y. S. Kim, J. Lee, H. Kornfeld, and G. Ostroff, “Glucan particle encapsulated rifampicin for targeted delivery to macrophages,” Polymers, vol. 2, no. 4, pp. 681–689, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Huang, G. R. Ostroff, C. K. Lee, C. A. Specht, and S. M. Levitz, “Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded β-glucan particles,” mBio, vol. 1, no. 3, Article ID e00164-10, 2010. View at Publisher · View at Google Scholar
  9. H. Huang, G. R. Ostroff, C. K. Lee, C. A. Specht, and S. M. Levitz, “Characterization and optimization of the glucan particle-based vaccine platform,” Clinical and Vaccine Immunology, vol. 20, no. 10, pp. 1585–1591, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. J. L. Cohen, Y. Shen, M. Aouadi et al., “Peptide-and amine-modified glucan particles for the delivery of therapeutic siRNA,” Molecular Pharmaceutics, vol. 13, no. 3, pp. 964–978, 2016. View at Publisher · View at Google Scholar
  11. R. De Smet, T. Demoor, S. Verschuere et al., “β-Glucan microparticles are good candidates for mucosal antigen delivery in oral vaccination,” Journal of Controlled Release, vol. 172, no. 3, pp. 671–678, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. G. D. Brown and S. Gordon, “Immune recognition: a new receptor for β-glucans,” Nature, vol. 413, no. 6851, pp. 36–37, 2001. View at Google Scholar
  13. L. R. Bernstein, “31Ga therapeutic gallium compounds,” in Metallotherapeutic Drugs and Metal-Based Diagnostic Agents: The Use of Metals in Medicine, M. Gielen and E. R. Tiekink, Eds., chapter 14, John Wiley & Sons, New York, NY, USA, 2005. View at Google Scholar
  14. O. Olakanmi, B. E. Britigan, and L. S. Schlesinger, “Gallium disrupts iron metabolism of mycobacteria residing within human macrophages,” Infection and Immunity, vol. 68, no. 10, pp. 5619–5627, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. L. R. Bernstein, “Mechanisms of therapeutic activity for gallium,” Pharmacological Reviews, vol. 50, no. 4, pp. 665–682, 1998. View at Google Scholar · View at Scopus
  16. P. Narayanasamy, B. L. Switzer, and B. E. Britigan, “Prolonged-acting, multi-targeting gallium nanoparticles potently inhibit growth of both HIV and mycobacteria in co-infected human macrophages,” Scientific Reports, vol. 5, article 8824, pp. 1–7, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. J. E. Bell, “The neuropathology of adult HIV infection,” Revue Neurologique, vol. 154, no. 12, pp. 816–829, 1998. View at Google Scholar · View at Scopus
  18. H. Onishi, “Detection of gallium with rhodamine B,” Analytical Chemistry, vol. 27, no. 5, p. 832, 1955. View at Publisher · View at Google Scholar · View at Scopus
  19. V. Hornung, A. Ablasser, M. Charrel-Dennis et al., “AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC,” Nature, vol. 458, no. 7237, pp. 514–518, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Musich, O. O'Connell, M. P. Gonzalez-Perez, C. A. Derdeyn, P. J. Peters, and P. R. Clapham, “HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages,” Retrovirology, vol. 12, no. 1, article 25, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. X. Wei, J. M. Decker, H. Liu et al., “Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy,” Antimicrobial Agents and Chemotherapy, vol. 46, no. 6, pp. 1896–1905, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Sato and T. Nakamura, “Thermal decomposition of gallium hydroxides,” Thermochimica Acta, vol. 53, no. 3, pp. 281–288, 1982. View at Publisher · View at Google Scholar · View at Scopus
  23. P. J. Peters, J. Bhattacharya, S. Hibbitts et al., “Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages,” Journal of Virology, vol. 78, no. 13, pp. 6915–6926, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. P. J. Peters, W. M. Sullivan, M. J. Duenas-Decamp et al., “Non-macrophage-tropic human immunodeficiency virus type 1 R5 envelopes predominate in blood, lymph nodes, and semen: implications for transmission and pathogenesis,” Journal of Virology, vol. 80, no. 13, pp. 6324–6332, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. K. C. Jambo, D. H. Banda, A. M. Kankwatira et al., “Small alveolar macrophages are infected preferentially by HIV and exhibit impaired phagocytic function,” Mucosal Immunology, vol. 7, no. 5, pp. 1116–1126, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. S. K. Cribbs, J. Lennox, A. M. Caliendo, L. A. Brown, and D. M. Guidot, “Healthy HIV-1-infected individuals on highly active antiretroviral therapy harbor HIV-1 in their alveolar macrophages,” AIDS Research and Human Retroviruses, vol. 31, no. 1, pp. 64–70, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. V. Roulet, A.-P. Satie, A. Ruffault et al., “Susceptibility of human testis to human immunodeficiency virus-1 infection in situ and in vitro,” The American Journal of Pathology, vol. 169, no. 6, pp. 2094–2103, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. S. B. Joseph, R. Swanstrom, A. D. M. Kashuba, and M. S. Cohen, “Bottlenecks in HIV-1 transmission: insights from the study of founder viruses,” Nature Reviews Microbiology, vol. 13, no. 7, pp. 414–425, 2015. View at Publisher · View at Google Scholar · View at Scopus